All In MedTech

FDA Clearance Tracker · P860057-S015

CARPENTIER-EDWARDS PERIMOUNT PERICARDIAL BIOPROSTHESIS MODEL 6900 MITRAL

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 15, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 15, 2001

Approved

Time to decision

217 days

Received Oct 10, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P860057-S015
Device name
CARPENTIER-EDWARDS PERIMOUNT PERICARDIAL BIOPROSTHESIS MODEL 6900 MITRAL
Applicant location
Irvine, CA
Received
Oct 10, 2000
Decided
May 15, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Postapproval Study Protocol
Original approval
P860057

Device type

Device class
Class III
Regulation
21 CFR 870.3925

Every decision under product code DYE

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE POST-APPROVAL STUDY PROTOCOLS AND FOR A LABELING REVISION BASED ON THE RESULTS OF THE MAGNETIC RESONANCE IMAGING STUDY.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.